The excitement around R GLP-3 shows how quickly obesity medicine is changing. Over only a
few years, the field has moved from single-hormone drugs to multi-receptor therapies
designed to work on several metabolic signals at once.
https://novabioresearch.co.uk/product/retatrutide-40mg-2/